Patent 7696163 was granted and assigned to Novo Nordisk on April, 2010 by the United States Patent and Trademark Office.
The invention includes methods and compositions for remodeling a peptide molecule, including the addition or deletion of one or more glycosyl groups to a peptide, and/or the addition of a modifying group to a peptide.